Biocept Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- S&P Global explores potential separation of Capital IQ business
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Biocept (BIOC) Reports Q3 Loss of $2.42/Share
November 13, 2018 4:11 PM ESTBiocept (NASDAQ: BIOC) reported Q3 EPS of ($2.42), versus ($5.90) reported last year. Revenue for the quarter came in at $762 thousand, versus $1.1 million reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
... More


